| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Palliative Care | 28 | 2025 | 438 | 2.800 |
Why?
|
| Neoplasms | 39 | 2025 | 2848 | 2.250 |
Why?
|
| Survivors | 16 | 2016 | 346 | 2.050 |
Why?
|
| Terminal Care | 10 | 2021 | 116 | 1.410 |
Why?
|
| Patient Navigation | 7 | 2018 | 23 | 1.320 |
Why?
|
| Quality of Life | 19 | 2023 | 2023 | 1.290 |
Why?
|
| Telemedicine | 5 | 2022 | 486 | 1.120 |
Why?
|
| Self Care | 3 | 2017 | 226 | 0.950 |
Why?
|
| Caregivers | 10 | 2020 | 553 | 0.950 |
Why?
|
| Medicare | 8 | 2019 | 418 | 0.780 |
Why?
|
| Advance Care Planning | 4 | 2018 | 40 | 0.760 |
Why?
|
| Breast Neoplasms | 5 | 2024 | 2582 | 0.750 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2022 | 86 | 0.710 |
Why?
|
| Aged | 46 | 2025 | 20005 | 0.680 |
Why?
|
| Patient Education as Topic | 5 | 2019 | 452 | 0.640 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2019 | 481 | 0.610 |
Why?
|
| Fatigue | 3 | 2017 | 194 | 0.600 |
Why?
|
| Stress, Psychological | 8 | 2017 | 547 | 0.580 |
Why?
|
| Decision Making | 3 | 2018 | 667 | 0.560 |
Why?
|
| Aged, 80 and over | 27 | 2025 | 6552 | 0.560 |
Why?
|
| Hospice Care | 5 | 2019 | 29 | 0.530 |
Why?
|
| Cancer Pain | 1 | 2017 | 25 | 0.510 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2014 | 1301 | 0.500 |
Why?
|
| Continuity of Patient Care | 2 | 2018 | 142 | 0.480 |
Why?
|
| Patient Care Planning | 2 | 2016 | 122 | 0.480 |
Why?
|
| Cognitive Dysfunction | 2 | 2023 | 283 | 0.470 |
Why?
|
| Emergency Medical Services | 2 | 2017 | 397 | 0.470 |
Why?
|
| Self-Management | 1 | 2017 | 111 | 0.460 |
Why?
|
| Transitional Care | 1 | 2015 | 16 | 0.450 |
Why?
|
| Restraint, Physical | 1 | 2015 | 31 | 0.450 |
Why?
|
| Female | 55 | 2025 | 67915 | 0.440 |
Why?
|
| Humans | 84 | 2025 | 126089 | 0.430 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2006 | 96 | 0.430 |
Why?
|
| Chronic Disease | 2 | 2017 | 1187 | 0.420 |
Why?
|
| Survival Rate | 10 | 2018 | 2060 | 0.420 |
Why?
|
| Health Status | 2 | 2017 | 380 | 0.410 |
Why?
|
| Middle Aged | 31 | 2025 | 27331 | 0.400 |
Why?
|
| Cognition Disorders | 3 | 2015 | 542 | 0.400 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 130 | 0.390 |
Why?
|
| Male | 48 | 2025 | 62089 | 0.380 |
Why?
|
| Volunteers | 4 | 2015 | 22 | 0.380 |
Why?
|
| Self Report | 1 | 2015 | 535 | 0.360 |
Why?
|
| Disease Management | 2 | 2016 | 533 | 0.350 |
Why?
|
| Heart Failure | 6 | 2020 | 2175 | 0.320 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2010 | 61 | 0.320 |
Why?
|
| Hospice and Palliative Care Nursing | 2 | 2020 | 18 | 0.320 |
Why?
|
| Feasibility Studies | 5 | 2025 | 790 | 0.300 |
Why?
|
| Social Support | 4 | 2018 | 371 | 0.300 |
Why?
|
| Communication | 4 | 2018 | 513 | 0.300 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 883 | 0.300 |
Why?
|
| Veterans | 3 | 2015 | 1731 | 0.300 |
Why?
|
| Brain Neoplasms | 3 | 2018 | 1224 | 0.290 |
Why?
|
| Adaptation, Psychological | 5 | 2018 | 429 | 0.290 |
Why?
|
| Medical Oncology | 5 | 2017 | 229 | 0.290 |
Why?
|
| Health Expenditures | 3 | 2018 | 132 | 0.280 |
Why?
|
| Adult | 20 | 2025 | 30254 | 0.270 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2024 | 667 | 0.270 |
Why?
|
| Gastroscopy | 1 | 2007 | 95 | 0.270 |
Why?
|
| Liability, Legal | 1 | 2007 | 48 | 0.260 |
Why?
|
| United States | 16 | 2023 | 11204 | 0.260 |
Why?
|
| Gastrostomy | 1 | 2007 | 88 | 0.260 |
Why?
|
| Patient Participation | 3 | 2017 | 230 | 0.240 |
Why?
|
| Family | 2 | 2020 | 574 | 0.240 |
Why?
|
| Alabama | 7 | 2019 | 44 | 0.230 |
Why?
|
| Glioblastoma | 1 | 2009 | 332 | 0.230 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2025 | 202 | 0.230 |
Why?
|
| Cancer Survivors | 2 | 2019 | 256 | 0.230 |
Why?
|
| Professional-Patient Relations | 2 | 2018 | 95 | 0.230 |
Why?
|
| Enteral Nutrition | 1 | 2007 | 279 | 0.230 |
Why?
|
| Health Promotion | 3 | 2024 | 400 | 0.220 |
Why?
|
| Ethics, Medical | 1 | 2007 | 399 | 0.220 |
Why?
|
| Patient Care Team | 2 | 2022 | 548 | 0.220 |
Why?
|
| Social Work | 2 | 2015 | 20 | 0.220 |
Why?
|
| Uncompensated Care | 1 | 2004 | 12 | 0.220 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 1281 | 0.220 |
Why?
|
| Mobile Health Units | 1 | 2024 | 24 | 0.220 |
Why?
|
| Health Personnel | 3 | 2019 | 531 | 0.220 |
Why?
|
| Medically Uninsured | 1 | 2024 | 75 | 0.210 |
Why?
|
| Hospitalization | 5 | 2018 | 1838 | 0.210 |
Why?
|
| Hospices | 2 | 2019 | 7 | 0.210 |
Why?
|
| Depression | 4 | 2017 | 1292 | 0.200 |
Why?
|
| Mammography | 1 | 2024 | 129 | 0.200 |
Why?
|
| Surveys and Questionnaires | 7 | 2025 | 3905 | 0.200 |
Why?
|
| Hospitals, Veterans | 2 | 2016 | 333 | 0.200 |
Why?
|
| Qualitative Research | 3 | 2017 | 658 | 0.200 |
Why?
|
| Emergency Treatment | 2 | 2014 | 76 | 0.200 |
Why?
|
| Exercise | 4 | 2019 | 837 | 0.200 |
Why?
|
| Anxiety | 3 | 2023 | 962 | 0.180 |
Why?
|
| Pilot Projects | 4 | 2025 | 1386 | 0.170 |
Why?
|
| Critical Care | 2 | 2024 | 661 | 0.170 |
Why?
|
| Patient Selection | 3 | 2017 | 702 | 0.170 |
Why?
|
| Biological Products | 1 | 2023 | 136 | 0.170 |
Why?
|
| Comorbidity | 5 | 2017 | 1538 | 0.170 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 457 | 0.170 |
Why?
|
| Prospective Studies | 4 | 2017 | 6093 | 0.170 |
Why?
|
| Attitude of Health Personnel | 2 | 2024 | 693 | 0.170 |
Why?
|
| Interdisciplinary Studies | 1 | 2020 | 5 | 0.160 |
Why?
|
| Southeastern United States | 2 | 2019 | 32 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2022 | 4920 | 0.160 |
Why?
|
| Follow-Up Studies | 6 | 2023 | 5050 | 0.160 |
Why?
|
| Interviews as Topic | 3 | 2017 | 422 | 0.160 |
Why?
|
| Health Services Needs and Demand | 2 | 2018 | 168 | 0.160 |
Why?
|
| Healthy Lifestyle | 1 | 2019 | 32 | 0.150 |
Why?
|
| Rural Health Services | 1 | 2019 | 27 | 0.150 |
Why?
|
| Patient Care | 2 | 2016 | 99 | 0.150 |
Why?
|
| Self Efficacy | 2 | 2017 | 198 | 0.140 |
Why?
|
| Pain | 3 | 2021 | 428 | 0.140 |
Why?
|
| Health Care Costs | 2 | 2018 | 383 | 0.140 |
Why?
|
| Age Factors | 5 | 2018 | 2772 | 0.130 |
Why?
|
| Patients | 1 | 2018 | 122 | 0.130 |
Why?
|
| Survivorship | 1 | 2017 | 46 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 313 | 0.130 |
Why?
|
| Menopause | 1 | 2017 | 83 | 0.130 |
Why?
|
| Focus Groups | 2 | 2015 | 215 | 0.130 |
Why?
|
| Prescription Drugs | 1 | 2017 | 51 | 0.130 |
Why?
|
| Symptom Assessment | 1 | 2017 | 108 | 0.130 |
Why?
|
| Pandemics | 1 | 2024 | 1132 | 0.130 |
Why?
|
| Home Care Services | 2 | 2014 | 68 | 0.130 |
Why?
|
| Insurance, Health | 1 | 2017 | 133 | 0.130 |
Why?
|
| Pharmaceutical Preparations | 1 | 2017 | 81 | 0.120 |
Why?
|
| Emergency Service, Hospital | 3 | 2018 | 1025 | 0.120 |
Why?
|
| Regression Analysis | 3 | 2017 | 757 | 0.120 |
Why?
|
| Health Behavior | 2 | 2019 | 386 | 0.120 |
Why?
|
| Counseling | 1 | 2018 | 232 | 0.120 |
Why?
|
| Health Resources | 1 | 2017 | 126 | 0.120 |
Why?
|
| Treatment Outcome | 9 | 2020 | 12328 | 0.120 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 3649 | 0.120 |
Why?
|
| Tertiary Prevention | 1 | 2015 | 2 | 0.120 |
Why?
|
| Prognosis | 4 | 2018 | 4709 | 0.110 |
Why?
|
| Nursing Research | 1 | 2015 | 17 | 0.110 |
Why?
|
| Aftercare | 1 | 2016 | 149 | 0.110 |
Why?
|
| Sleep Wake Disorders | 2 | 2014 | 188 | 0.110 |
Why?
|
| Life Style | 2 | 2015 | 433 | 0.110 |
Why?
|
| Community-Based Participatory Research | 1 | 2015 | 59 | 0.110 |
Why?
|
| Retrospective Studies | 9 | 2019 | 16770 | 0.110 |
Why?
|
| Helping Behavior | 1 | 2014 | 6 | 0.110 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1421 | 0.110 |
Why?
|
| Patient Compliance | 1 | 2017 | 458 | 0.100 |
Why?
|
| Psychotherapy, Group | 1 | 2014 | 57 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 427 | 0.100 |
Why?
|
| Ambulatory Care | 2 | 2013 | 392 | 0.100 |
Why?
|
| Occupational Diseases | 1 | 2014 | 75 | 0.100 |
Why?
|
| Medical Staff, Hospital | 1 | 2014 | 92 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 3 | 2015 | 1227 | 0.100 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2014 | 85 | 0.100 |
Why?
|
| Immunization | 1 | 2014 | 301 | 0.100 |
Why?
|
| Communicable Diseases | 1 | 2014 | 153 | 0.090 |
Why?
|
| Outpatients | 1 | 2014 | 254 | 0.090 |
Why?
|
| Pain Management | 1 | 2014 | 195 | 0.090 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 664 | 0.090 |
Why?
|
| Chronic Pain | 1 | 2014 | 141 | 0.090 |
Why?
|
| Memory | 1 | 2015 | 345 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 866 | 0.090 |
Why?
|
| Diet | 2 | 2015 | 1102 | 0.090 |
Why?
|
| Erectile Dysfunction | 1 | 2014 | 194 | 0.090 |
Why?
|
| Motor Activity | 1 | 2014 | 504 | 0.090 |
Why?
|
| Referral and Consultation | 3 | 2024 | 556 | 0.080 |
Why?
|
| Inpatients | 3 | 2021 | 539 | 0.080 |
Why?
|
| Mental Health Services | 1 | 2013 | 259 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 418 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2015 | 976 | 0.080 |
Why?
|
| Activities of Daily Living | 2 | 2009 | 403 | 0.080 |
Why?
|
| Cognition | 1 | 2015 | 783 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 316 | 0.080 |
Why?
|
| Vaccination | 1 | 2014 | 1004 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2011 | 464 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 620 | 0.070 |
Why?
|
| Risk Factors | 2 | 2015 | 10397 | 0.070 |
Why?
|
| Executive Function | 1 | 2009 | 117 | 0.070 |
Why?
|
| Affect | 2 | 2020 | 167 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 377 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 731 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2010 | 269 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1231 | 0.070 |
Why?
|
| Tracheotomy | 1 | 2007 | 35 | 0.070 |
Why?
|
| Young Adult | 4 | 2019 | 9616 | 0.060 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 399 | 0.060 |
Why?
|
| Pain Measurement | 2 | 2020 | 345 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 822 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 952 | 0.060 |
Why?
|
| Psychometrics | 1 | 2009 | 655 | 0.060 |
Why?
|
| Texas | 2 | 2024 | 3532 | 0.060 |
Why?
|
| Informed Consent | 1 | 2007 | 336 | 0.060 |
Why?
|
| Persuasive Communication | 1 | 2024 | 11 | 0.050 |
Why?
|
| Medical Audit | 2 | 2016 | 96 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 1494 | 0.050 |
Why?
|
| Guidelines as Topic | 2 | 2014 | 192 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2023 | 184 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 2024 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2004 | 436 | 0.050 |
Why?
|
| Patient Comfort | 1 | 2021 | 5 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 2936 | 0.040 |
Why?
|
| Advance Directives | 1 | 2021 | 32 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 232 | 0.040 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 33 | 0.040 |
Why?
|
| Health Services for the Aged | 1 | 2018 | 34 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 1175 | 0.040 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2018 | 35 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 660 | 0.040 |
Why?
|
| Smoking Cessation | 1 | 2019 | 181 | 0.030 |
Why?
|
| New Hampshire | 1 | 2017 | 6 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 280 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2018 | 170 | 0.030 |
Why?
|
| Forecasting | 1 | 2019 | 350 | 0.030 |
Why?
|
| Drug Costs | 1 | 2017 | 61 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2017 | 33 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 150 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2018 | 142 | 0.030 |
Why?
|
| Learning | 1 | 2020 | 355 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2018 | 283 | 0.030 |
Why?
|
| Urban Health | 1 | 2016 | 74 | 0.030 |
Why?
|
| Perception | 1 | 2017 | 227 | 0.030 |
Why?
|
| Weight Loss | 1 | 2019 | 503 | 0.030 |
Why?
|
| Geriatrics | 1 | 2016 | 62 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2015 | 3461 | 0.030 |
Why?
|
| Patient Acuity | 1 | 2015 | 63 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2015 | 53 | 0.030 |
Why?
|
| Patient Preference | 1 | 2017 | 142 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2015 | 72 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1216 | 0.030 |
Why?
|
| Wakefulness-Promoting Agents | 1 | 2014 | 1 | 0.030 |
Why?
|
| Employment | 1 | 2015 | 68 | 0.030 |
Why?
|
| Behavior | 1 | 2014 | 69 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2017 | 390 | 0.030 |
Why?
|
| Methylphenidate | 1 | 2014 | 55 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1189 | 0.030 |
Why?
|
| Occupational Therapy | 1 | 2014 | 36 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 130 | 0.030 |
Why?
|
| Weight Reduction Programs | 1 | 2014 | 58 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 2014 | 72 | 0.030 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 123 | 0.030 |
Why?
|
| Psychology | 1 | 2013 | 56 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 299 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 1324 | 0.030 |
Why?
|
| Physician's Role | 1 | 2015 | 160 | 0.020 |
Why?
|
| Rural Population | 1 | 2015 | 244 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 529 | 0.020 |
Why?
|
| Education, Medical | 1 | 2017 | 283 | 0.020 |
Why?
|
| Carboplatin | 1 | 2013 | 77 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2013 | 108 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2013 | 82 | 0.020 |
Why?
|
| Motivation | 1 | 2015 | 322 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 222 | 0.020 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2016 | 687 | 0.020 |
Why?
|
| Research Design | 1 | 2016 | 687 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3303 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3680 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2013 | 261 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 727 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 1294 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2015 | 392 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 970 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 19936 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 216 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 440 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2015 | 771 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6016 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1096 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 2579 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 2007 | 25 | 0.020 |
Why?
|
| Ventilator Weaning | 1 | 2007 | 30 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 615 | 0.020 |
Why?
|
| Nurse's Role | 1 | 2007 | 40 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1757 | 0.020 |
Why?
|
| Safety | 1 | 2007 | 208 | 0.020 |
Why?
|
| Dyspnea | 1 | 2007 | 130 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2019 | 8358 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2007 | 369 | 0.010 |
Why?
|
| Infant | 1 | 2019 | 12762 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 14329 | 0.010 |
Why?
|
| Child | 1 | 2019 | 25062 | 0.010 |
Why?
|